Skip to main content

Peer Review reports

From: SARIFA as a new histopathological biomarker is associated with adverse clinicopathological characteristics, tumor-promoting fatty-acid metabolism, and might predict a metastatic pattern in pT3a prostate cancer

Original Submission
13 Oct 2023 Submitted Original manuscript
19 Nov 2023 Reviewed Reviewer Report
27 Nov 2023 Reviewed Reviewer Report
5 Dec 2023 Author responded Author comments - Nic G. Reitsam
Resubmission - Version 2
5 Dec 2023 Submitted Manuscript version 2
7 Dec 2023 Author responded Author comments - Nic G. Reitsam
Resubmission - Version 3
7 Dec 2023 Submitted Manuscript version 3
12 Dec 2023 Reviewed Reviewer Report
17 Dec 2023 Reviewed Reviewer Report
Resubmission - Version 4
Submitted Manuscript version 4
Publishing
17 Dec 2023 Editorially accepted
12 Jan 2024 Article published 10.1186/s12885-023-11771-9

You can find further information about peer review here.

Back to article page